Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Paul_Perreault
|
| gptkbp:country |
gptkb:Australia
|
| gptkbp:founded |
1916
|
| gptkbp:headquarters_location |
gptkb:Melbourne,_Australia
|
| https://www.w3.org/2000/01/rdf-schema#label |
CSL (company)
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:numberOfEmployees |
over 25,000
|
| gptkbp:products |
vaccines
plasma-derived therapies recombinant proteins |
| gptkbp:stockExchange |
gptkb:ASX
|
| gptkbp:stockSymbol |
gptkb:CSL
|
| gptkbp:subsidiary |
gptkb:CSL_Behring
gptkb:Seqirus |
| gptkbp:website |
https://www.csl.com/
|
| gptkbp:bfsParent |
gptkb:CSL
|
| gptkbp:bfsLayer |
5
|